# Glycopyrrolate

NDC: 63323-578
Generic name: Glycopyrrolate
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20171027

FDA application: ANDA209328

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-578"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-578
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54458620-d888-4df6-ae4b-78c3dfed3423